Literature DB >> 26045079

Exploring the Effectiveness of Mandatory Premarital Screening and Genetic Counselling Programmes for β-Thalassaemia in the Middle East: A Scoping Review.

Marwa Saffi1, Natasha Howard.   

Abstract

BACKGROUND: β-Thalassaemia is a common genetic blood disorder in the Middle Eastern region. Mandatory premarital screening and genetic counselling (PMSGC) programmes are implemented in 8 Middle East countries to reduce at-risk marriages and thus disease prevalence. A scoping review was conducted to explore the effectiveness of these programmes.
METHODS: The 6-stage scoping framework of Arksey and O'Malley [Int J Soc Res Methodol 2005;8:19-32] was used. Reported outcomes were analysed per country, with success defined as achieving a 65% reduction in at-risk marriages and/or thalassaemia-affected births. Emergent enablers and barriers were analysed thematically.
RESULTS: Twenty-one sources were included from the 1,348 identified, discussing 7 country programmes, with 95% (20/21) published during 2003-2013. Five publications each were included for Iran and Saudi Arabia, 3 for Turkey, 2 each for Bahrain and Iraq (Kurdistan), and 1 for the United Arab Emirates, plus 2 multi-country evaluations. No programme achieved a 65% at-risk marriage cancellation rate. Though data on thalassaemia-affected birth reductions were minimal, programmes in Iran, Turkey and Iraq reported at least 65% reductions. A thematic analysis found that screening timing, access to prenatal detection and abortion, socio-religious issues, awareness and counselling affected decisions.
CONCLUSION: This review found that PMSGC programmes were unsuccessful in discouraging at-risk marriages but successful in reducing the prevalence of affected births in countries providing prenatal detection and therapeutic abortion. A life cycle approach to prevention, incorporation of school screening, awareness campaigns, reconsideration of therapeutic abortion, and screening and counselling of couples married prior to programme inception are likely to improve the effectiveness of such programmes in the Middle Eastern region.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26045079     DOI: 10.1159/000430837

Source DB:  PubMed          Journal:  Public Health Genomics        ISSN: 1662-4246            Impact factor:   2.000


  26 in total

1.  Undiagnosed haemoglobinopathies among pregnant women attending antenatal care clinics in Pune, India.

Authors:  Sumedha Dharmarajan; Ameya Pawar; Prajkta Bhide; Anita Kar
Journal:  J Community Genet       Date:  2021-01-24

2.  Attitudes and impact among people with abnormal premarital screening test results in Muscat governorate's primary healthcare centers in 2018.

Authors:  Manar Al Sanaa Ali Al Zeedi; Zahir Ghassan Al Abri
Journal:  J Community Genet       Date:  2020-11-21

3.  Should Premarital Screening for Blood Disorders be an Obligatory Measure in Oman?

Authors:  Amal A Al-Balushi; Budoor Al-Hinai
Journal:  Sultan Qaboos Univ Med J       Date:  2018-04-04

4.  Prenatal Diagnosis of HbE-β-Thalassemia: Experience of a Center in Western India.

Authors:  Roshan Colah; Anita Nadkarni; Ajit Gorakshakar; Pratibha Sawant; Khushnooma Italia; Dipti Upadhye; Harshali Gaikwad; Kanjaksha Ghosh
Journal:  Indian J Hematol Blood Transfus       Date:  2017-09-04       Impact factor: 0.900

5.  Knowledge and Perception of and Attitude toward a Premarital Screening Program in Qatar: A Cross-Sectional Study.

Authors:  Mashael Al-Shafai; Aisha Al-Romaihi; Noora Al-Hajri; Nazmul Islam; Karam Adawi
Journal:  Int J Environ Res Public Health       Date:  2022-04-06       Impact factor: 3.390

6.  Responsible implementation of expanded carrier screening.

Authors:  Lidewij Henneman; Pascal Borry; Davit Chokoshvili; Martina C Cornel; Carla G van El; Francesca Forzano; Alison Hall; Heidi C Howard; Sandra Janssens; Hülya Kayserili; Phillis Lakeman; Anneke Lucassen; Sylvia A Metcalfe; Lovro Vidmar; Guido de Wert; Wybo J Dondorp; Borut Peterlin
Journal:  Eur J Hum Genet       Date:  2016-03-16       Impact factor: 4.246

7.  Distribution of β-Thalassemia and Other Hemoglobinopathies in Bangladeshi University Students and Ready-Made Garment Workers.

Authors:  Mohammad Manirul Islam; Najmuj Sakib; Fahima Hossain; Zebunnesa Zeba; A K M Israfil Bhuiyan; Mohammed A Mamun; Mark Mohan Kaggwa; Ken Yoshimura; Sadia Afrin; Sheikh Selim; Moazzem Hossain
Journal:  Risk Manag Healthc Policy       Date:  2021-06-24

8.  Investigation of molecular heterogeneity of β-thalassemia disorder in District Charsadda of Pakistan.

Authors:  Muhammad Shakeel; Muhammad Arif; Shoaib Ur Rehman; Tabassum Yaseen
Journal:  Pak J Med Sci       Date:  2016 Mar-Apr       Impact factor: 1.088

9.  Early detection of myocardial dysfunction in poorly treated pediatric thalassemia children and adolescents: Two Saudi centers experience.

Authors:  Mohamed H Ibrahim; Ahmed A Azab; Naglaa M Kamal; Mostafa A Salama; Soha A Ebrahim; Ashraf M Shahin; Akram E El-Sadek; Waleid E Abdulghany; Laila M Sherief; Enas A A Abdallah
Journal:  Ann Med Surg (Lond)       Date:  2016-05-21

10.  Assessment of Factors Associated with the Effectiveness of Premarital Screening for Hemoglobinopathies in the South of Saudi Arabia.

Authors:  Ibrahim M Gosadi; Gassem A Gohal; Alanoud E Dalak; Anas A Alnami; Norah A Aljabri; Atyaf J Zurayyir
Journal:  Int J Gen Med       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.